Staff Members - Benha University
Benefit Of Doxycycline Therapy In Acute St Elevation myocardial Infarction with Left Ventricular Dysfunction treated with primary percutaneous coronary intervention (ppci)
• 2015
Publication Information
Authors
Mohamed Salem, MD, PhD. Mohamed Mahrous, MD. Emad Mahmoud, Msc. Elsayed abd Elkhalek, MD and Mohamed Selem, MD
Keywords
STEMI, remodeling, echocardiography
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: several randomized trials performed in the era of doxycycline showed reduction in myocardial remodeling when compared with control therapy.
Methods: this prospective study included 100 consecutive patients with acute anterior ST segment elevation myocardial infarction and left ventricular ejection fraction less than 40%.all patients under went primary PCI and were divided into two groups; Group I who received bolus dose 100 mg of doxycycline immediately after PPCI then a maintenance dose 100 mg b.i.d for 7 days and group II who received standard treatment. Echo left ventricular end diastolic volume index were determined at baseline and six month. Results: primary end point was reported The 6-month changes in % LVEDVI were significant decreased in the doxycycline group than in the control group [-13.2 ± 14.2 ml/m2 (26%) versus 7.4 ± 14.35 ml/m2 (14%) respectively p= 0.001], and left ventricular remodeling which was was reported in 60 % of all patients (42 % in group I versus 78 % in group II, P = 0.011). Conclusion: the result of current study suggest that doxycycline reduces the adverse LV remodeling for comparable to standard treatment in patients with acute anterior STEMI and LV dysfunction.
Methods: this prospective study included 100 consecutive patients with acute anterior ST segment elevation myocardial infarction and left ventricular ejection fraction less than 40%.all patients under went primary PCI and were divided into two groups; Group I who received bolus dose 100 mg of doxycycline immediately after PPCI then a maintenance dose 100 mg b.i.d for 7 days and group II who received standard treatment. Echo left ventricular end diastolic volume index were determined at baseline and six month. Results: primary end point was reported The 6-month changes in % LVEDVI were significant decreased in the doxycycline group than in the control group [-13.2 ± 14.2 ml/m2 (26%) versus 7.4 ± 14.35 ml/m2 (14%) respectively p= 0.001], and left ventricular remodeling which was was reported in 60 % of all patients (42 % in group I versus 78 % in group II, P = 0.011). Conclusion: the result of current study suggest that doxycycline reduces the adverse LV remodeling for comparable to standard treatment in patients with acute anterior STEMI and LV dysfunction.